The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
The drug, suzetrigine, is a 50-milligram prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx. “A new non-opioid analgesic ...
The agents, using K-9 dogs, uncovered thousands of synthetic opioids stashed in parcels transported to and from South ...
We are working closely with the Drug Control Department ... Legitimate use of Tydol tablets Tydol tablets are prescription drugs that should only be sold under a doctor’s supervision.